Audubon-based Globus Medical, a musculoskeletal solutions company, recently completed its merger with NuVasive.
The merger combines the companies’ portfolios in spine and orthopedics, and will expand the companies’ commercial reach, operational capabilities, and commitment to product development and surgeon education.
In addition, the merger offers revenue potential and a strong financial profile for value creation.
The combined company will enable technologies to impact patient care and provide surgeons and patients with one of the most comprehensive offerings of musculoskeletal procedural solutions.
“We’re thrilled to begin our journey together to create a leading global musculoskeletal company,” Dan Scavilla, Globus Medical president and CEO, said. “With a relentless focus on changing patient lives, we’re combining our differentiated portfolios and talented teams to reach more customers as we advance spine and orthopedic care globally.”
Under the terms of the agreement, Globus Medical will expand its board of directors from eight directors to 11.
“Our combination with NuVasive is a defining moment in our company’s history,” David Paul, Globus Medical executive chairman, said. “I’m incredibly proud of the strong legacy we’ve built at Globus Medical, and I look forward to delivering on the many opportunities for our surgeon customers and their patients as a combined company.”
Globus Medical will discuss the merger and the anticipated benefits during a November conference call.